Detalhe da pesquisa
1.
Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6.
Int J Mol Sci
; 25(10)2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791392
2.
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer.
Br J Cancer
; 129(7): 1071-1082, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568037
3.
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes.
BMC Med
; 21(1): 234, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400832
4.
Metal-Complexes Bearing Releasable CO Differently Modulate Amyloid Aggregation.
Inorg Chem
; 62(26): 10470-10480, 2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338927
5.
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study.
Future Oncol
; 18(21): 2643-2653, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608115
6.
Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Bioorg Chem
; 127: 106001, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803020
7.
Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.
Int J Mol Sci
; 23(23)2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499032
8.
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells.
Molecules
; 27(9)2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35566369
9.
Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
Bioorg Chem
; 113: 104997, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044346
10.
A Comparative Study of the Effects of Platinum (II) Complexes on ß-Amyloid Aggregation: Potential Neurodrug Applications.
Int J Mol Sci
; 22(6)2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809522
11.
EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer.
Cancer Lett
; 593: 216968, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788968
12.
Mapping Cellular Interactions from Spatially Resolved Transcriptomics Data.
bioRxiv
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781617
13.
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Nat Commun
; 15(1): 2287, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480701
14.
History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses.
Biochimie
; 206: 89-92, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273765
15.
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
Cancer Treat Rev
; 115: 102530, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898352
16.
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations.
EClinicalMedicine
; 62: 102113, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554126
17.
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer.
NPJ Breast Cancer
; 9(1): 48, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258566
18.
Targeting G-quadruplex motifs interferes with differentiation of adipose-derived mesenchymal stem cells.
Stem Cell Res Ther
; 14(1): 98, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076894
19.
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Cancers (Basel)
; 15(23)2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067406
20.
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Res Sq
; 2023 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502925